According to Sinopharm Holdings, Sinopharm Holdings and AstraZeneca recently held a high-level strategic cooperation exchange meeting in Shanghai and officially launched a special cooperation on basic drugs to benefit the people. As the core strategic partner of Sinopharm Holdings, AstraZeneca has formed deep collaboration in various core fields such as pharmaceutical circulation, innovative services, and people's livelihood and welfare. The launch of this project marks a focus on implementing the national basic drug policy and improving the accessibility of primary care. Cooperation between the two sides has progressed to a deeper level and a wider range of fields.

According to Sinopharm Holdings, Sinopharm Holdings and AstraZeneca recently held a high-level strategic cooperation exchange meeting in Shanghai and officially launched a special cooperation on basic drugs to benefit the people. As the core strategic partner of Sinopharm Holdings, AstraZeneca has formed deep collaboration in various core fields such as pharmaceutical circulation, innovative services, and people's livelihood and welfare. The launch of this project marks a focus on implementing the national basic drug policy and improving the accessibility of primary care. Cooperation between the two sides has progressed to a deeper level and a wider range of fields.